Cargando…

Which TDP-43 aggregates are toxic in ALS?

Detalles Bibliográficos
Autores principales:	Valle, Cristiana, Carrì, Maria Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347664/ https://www.ncbi.nlm.nih.gov/pubmed/27876701 http://dx.doi.org/10.18632/oncotarget.13461

Ejemplares similares

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
por: Deshimaru, Manami, et al.
Publicado: (2021)

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
por: Gruijs da Silva, Lara A, et al.
Publicado: (2022)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
por: Ormeño, Fernando, et al.
Publicado: (2020)

Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation
por: Candelise, Niccolò, et al.
Publicado: (2023)

ALS-Associated TDP-43 Induces Endoplasmic Reticulum Stress, Which Drives Cytoplasmic TDP-43 Accumulation and Stress Granule Formation
por: Walker, Adam K., et al.
Publicado: (2013)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
por: Rengifo-Gonzalez, Juan Carlos, et al.
Publicado: (2021)

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
por: Keating, Sean S., et al.
Publicado: (2023)

Inflammation Induces TDP-43 Mislocalization and Aggregation
por: Correia, Ana Sofia, et al.
Publicado: (2015)

A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
por: Shenouda, Marc, et al.
Publicado: (2022)

Metals in ALS TDP-43 Pathology
por: Koski, Lassi, et al.
Publicado: (2021)

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
por: Neumann, Manuela, et al.
Publicado: (2020)

TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins
por: Prpar Mihevc, S., et al.
Publicado: (2016)

Inhibition of TDP-43 Aggregation by Nucleic Acid Binding
por: Huang, Yi-Chen, et al.
Publicado: (2013)

Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
por: Afroz, Tariq, et al.
Publicado: (2017)

Endocytosis regulates TDP-43 toxicity and turnover
por: Liu, Guangbo, et al.
Publicado: (2017)

The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
por: Hergesheimer, Rudolf C, et al.
Publicado: (2019)

Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation
por: McCord, Bryony, et al.
Publicado: (2023)

Tandem detergent-extraction and immunoprecipitation of proteinopathy: Scalable enrichment of ALS-associated TDP-43 aggregates
por: Evangelista, Baggio A., et al.
Publicado: (2023)

Cysteine Modifications in the Pathogenesis of ALS
por: Valle, Cristiana, et al.
Publicado: (2017)

Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP
por: Feneberg, Emily, et al.
Publicado: (2021)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018)

Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation
por: Li, Huei-Ying, et al.
Publicado: (2011)

Reducing TDP-43 aggregation does not prevent its cytotoxicity
por: Liu, Rui, et al.
Publicado: (2013)

Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
por: Armakola, Maria, et al.
Publicado: (2012)

TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS
por: Droppelmann, Cristian A., et al.
Publicado: (2019)

The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity
por: Crippa, Valeria, et al.
Publicado: (2016)

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
por: Ding, Xuebing, et al.
Publicado: (2021)

In vitro prion-like behaviour of TDP-43 in ALS
por: Smethurst, Phillip, et al.
Publicado: (2016)

Low T-cell reactivity to TDP-43 peptides in ALS
por: Ramachandran, Swetha, et al.
Publicado: (2023)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Zhang, Lumi, et al.
Publicado: (2020)

RNA targets of TDP-43: Which one is more important in neurodegeneration?
por: Halim, Dilara, et al.
Publicado: (2022)

Electrostatic Repulsion Governs TDP-43 C-terminal Domain Aggregation
por: Mompeán, Miguel, et al.
Publicado: (2016)

BAG6 prevents the aggregation of neurodegeneration-associated fragments of TDP43
por: Kasu, Yasar Arfat T., et al.
Publicado: (2022)

Suppression of Linear Ubiquitination Ameliorates Cytoplasmic Aggregation of Truncated TDP-43
por: Zhang, Qiang, et al.
Publicado: (2022)

Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage
por: Kumar, Senthil T., et al.
Publicado: (2023)

Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
por: Matsukawa, Koji, et al.
Publicado: (2021)

The Aggregation and Neurotoxicity of TDP-43 and Its ALS-Associated 25 kDa Fragment Are Differentially Affected by Molecular Chaperones in Drosophila
por: Gregory, Jenna M., et al.
Publicado: (2012)

Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis
por: Rajaratnam, Saiswaroop, et al.
Publicado: (2023)

Liquid–Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation
por: Pakravan, Donya, et al.
Publicado: (2021)

A 43-kDa TDP-43 Species Is Present in Aggregates Associated with Frontotemporal Lobar Degeneration
por: Bosque, Patrick J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b3sliirqht3l9r1rp1g53gbqfg